Bremelanotide
Bremelanotide is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Independent research database
Explore structured compound records with identity, research context, evidence boundaries, safety notes and source links.
No records match this search in the current published dataset.
Bremelanotide is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
A GLP-1 receptor agonist with controlled clinical evidence for specific approved uses, where product status, jurisdiction, and formulation matter.
Tesamorelin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
A dual GIP/GLP-1 receptor agonist with strong clinical evidence in approved-product contexts and separate questions for compounded products.
Creatine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Elamipretide is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Metformin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Nicotinamide riboside is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
A NAD+ precursor studied in metabolism and aging-biology contexts, with stronger human relevance than many research peptides but still outcome-specific evidence.
Rapamycin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
An investigational triple GLP-1/GIP/glucagon receptor agonist with strong phase 2 signals but no approved-product status yet.
Acarbose is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Berberine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
A copper-binding tripeptide often discussed in skin, wound-context, and cosmetic research, with evidence varying sharply by formulation and outcome.
Glycine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Quercetin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Resveratrol is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Sermorelin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Spermidine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Taurine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Thymosin alpha-1 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Urolithin A is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Alpha-ketoglutarate is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
A synthetic peptide discussed for tissue repair and gastrointestinal models, with most public claims still relying on preclinical research.
CJC-1295 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Epitalon is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
Fisetin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Humanin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Ipamorelin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
KPV is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
LL-37 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Melanotan II is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
MOTS-c is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
NAD+ is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
Selank is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Semax is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
A peptide commonly associated with thymosin beta-4 discussions and recovery claims, where evidence must be separated by exact molecule and model.
AOD-9604 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
Cycloastragenol is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
DSIP is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
Coverage and method
Records are published only when identity, localization and minimum content requirements pass the page-quality gate.
Read the methodology